Treatment

Evidence-Based Practices Resource Center

SAMHSA is committed to improving prevention, treatment, and recovery support services for mental and substance use disorders. This new Evidence-Based Practices Resource Center aims to provide communities, clinicians, policy-makers and others in the field with the information and tools they need to incorporate evidence-based practices into their communities or clinical settings. The Resource Center contains a collection of scientifically-based resources for a broad range of audiences, including Treatment Improvement Protocols, toolkits, resource guides, clinical practice

Reentry for Citizens Needing Substance Use Disorder Treatment

Online,

Prisons and jails are the largest behavioural health treatment institutions/organizations in every state, and often, especially for those with substance use disorders and mental health conditions, jail or prison are the entry points to Behavioral Health treatment. Once individuals with substance use disorders are released from prison, they have a greater risk of disrupted behavioural health treatment and even fatal overdose.

The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment

Citation
Ornell, F., Moura, H. F., Scherer, J. N., Pechansky, F., Kessler, F., & von Diemen, L. (2020). The COVID-19 pandemic and its impact on substance use: implications for prevention and treatment. Psychiatry research, 113096. Chicago

Abstract

The COVID-19 pandemic has brought major challenges to healthcare systems and public health policies globally, as it requires novel treatment and prevention strategies to adapt for the impact of the pandemic. Individuals with substance use disorders (SUD) are at risk population for contamination due to multiple factors—attributable to their clinical, psychological and psychosocial conditions.

IOTOD 2020 Virtual Conference

London,

Virtual Summit 2020
Date: 24th and 25th September 2020

The Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) team are delighted to announce that IOTOD 2020 is going virtual. In light of ongoing restrictions to travel and public gatherings and our commitment to the safety of our delegates, exhibitors and staff, this year’s conference will be delivered online.

It’s not what you say, but how you say it- Motivational Interviewing & Beyond Live Webinars

Motivational Interviewing & Beyond Live Webinars

A bad experience can be the best teacher.

Joel Porter, Steve Rollnick, Russell Calderwood, David Rosengren & others discuss the importance of learning from experience and language in working with people in the classroom, therapy office and playing field.

Levamisol: Un Adulterante Tóxico Encontrado en Drogas Ilegales Que se Consumen en las Calles

Published by
Colombo Plan, Fredric Rieder Family Foundation, JMJ Technologies

Alerta Global en Materia de Salud Pública

Los encargados del tratamiento por abuso de sustancias, los médicos clínicos, los extensionistas, las clínicas de salud pública, etc. deben conocer la información que se detalla a continuación. Un adulterante de drogas peligroso -el levamisol- aparece cada vez con mayor frecuencia en drogas ilegales como la cocaína en polvo y el crack, y en cierta medida en la heroína y el fentanilo.

Experiences of Clinicians Transitioning to Telemedicine

Citation
Uscher-Pines, L., Sousa, J., Raja, P., Mehrotra, A., Barnett, M., & Huskamp, H. A. (2020). Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine. Journal of Substance Abuse Treatment, 108124. Chicago

The COVID-19 pandemic has forced many practitioners to shift their practice online, using telemedicine to treat Opioid Use Disorder. This has allowed for the continuity of essential care whilst adhering to the social distancing guidelines, which protect people from the spread of infection.